Quantcast
Last updated on April 20, 2014 at 14:04 EDT

Latest Bioquark Inc. Stories

2014-03-13 23:22:29

Bioquark Inc., a company focused on the development of novel biologic based products to alter the regulatory state of human tissues and organs, with the goal of curing a wide range of diseases, as well as effecting complex regeneration, is adding to its team with a leading expert in the area of applied regenerative medicine and cellular therapies. Philadelphia, PA (PRWEB) March 13, 2014 Bioquark, Inc., (http://www.bioquark.com) a company focused on the development of combinatorial...

2014-01-23 23:21:30

Bioquark Inc., a company focused on the development of novel biologic based products to alter the regulatory state of human tissues and organs, with the goal of curing a wide range of diseases, as well as effecting complex regeneration, is adding to its team with a leading expert in the functional application of anti-aging regenerative and stem cell medicine. Philadelphia, PA (PRWEB) January 23, 2014 Bioquark, Inc., (http://www.bioquark.com) a company focused on the development of...

2013-11-05 23:26:25

Our definitions of death, specifically the death of the human brain, may have to change in the near future. This initial exchange between Bioquark Inc., a novel development stage company focused on biological approaches to human regeneration and repair, and Dr. Calixto Machado, MD, PhD, a world leading researcher in brain death, coma, and vegetative states, is an important step in realization of the transformational changes that are coming. Philadelphia, PA (PRWEB) November 05, 2013...

2012-08-29 06:25:26

PHILADELPHIA, Aug. 29, 2012 /PRNewswire/ -- Bioquark, Inc., (www.bioquark.com) a biopharmaceutical company engaged in the development of proprietary biological drugs that can be simultaneously leveraged for both the regeneration and repair of human organs and tissues, today announced that Ira S. Pastor, Chief Executive Officer, will present the Company's overview at the Rodman and Renshaw Annual Global Investment Conference's (14(th) Annual Healthcare Conference) on Tuesday, September 11,...

2012-03-21 06:24:44

TAMPA, Fla., March 21, 2012 /PRNewswire/ -- Bioquark Inc., (www.bioquark.com) a biopharmaceutical company developing proprietary biological drugs for regeneration and repair of human organs and tissues, announced today that it has retained the services of JSBarkats PLLC to represent Bioquark in all aspects of the company's SEC compliance and securities legal work, as well as help with structuring future financing for the company. "We are pleased to be working with the seasoned group...